Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Having a healthier heart associated with better problem-solving and reaction time
General Research
17 May 2021
People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to a study involving University of Oxford and Queen Mary University of London (QMUL) researchers.
COVID vaccine hesitancy: spell out the personal rather than collective benefits to persuade people – new research
Coronavirus COVID-19 General Research
17 May 2021
Dunbar’s number: why my theory that humans can only maintain 150 friendships has withstood 30 years of scrutiny
General Research
17 May 2021
COVID-19: is obesity really more of a risk factor for men than women?
Coronavirus COVID-19 General Research
12 May 2021
3,400 different medicines used globally to treat COVID-19
Coronavirus COVID-19 General Research
11 May 2021
Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study.
Children and Adolescents’ Mental Health: One Year On
Coronavirus COVID-19 General Research
10 May 2021
Parents and carers reported that behavioural, emotional and attentional difficulties in their children changed considerably throughout the past year, increasing in times of national lockdown and decreasing as restrictions eased and schools reopened, according to the latest Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study, led by experts at the University of Oxford.
Future-Proofing Mental Health
General Research
10 May 2021
UK academics are calling for targets for mental health research in order to meet the healthcare challenges of the next decade. Published today in Journal of Mental Health, researchers set out four overarching goals that will speed up implementation of mental health research and give a clear direction for researchers and funders to focus their efforts when it comes to better understanding the treatment of mental health.
Promising malaria vaccine enters final stage of clinical testing in West Africa
Clinical Trials General Research
7 May 2021
First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at the University of Oxford. Known as R21/Matrix-M, it recently showed efficacy of 77% over 12 months in a phase IIb trial, and it is hoped that this phase III trial will help to lead to licensure of this malaria vaccine by 2023.
Study reveals the three most important aspects of care for hip fractures
General Research
5 May 2021
Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.
Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices
General Research
5 May 2021
Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.
Why we must expand newborn screening
General Research
4 May 2021
Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.
Severe COVID in young people can mostly be explained by obesity – new study
General Research
4 May 2021
Oxford vaccine professor: rich countries have a moral duty to share their COVID-19 shots
Coronavirus COVID-19 General Research
30 April 2021
The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19
Coronavirus COVID-19 General Research
30 April 2021
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
New method for cost-effective genome-wide DNA methylation analysis
General Research
28 April 2021
Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
Azithromycin not effective against COVID-19, trial confirms
Clinical Trials General Research
28 April 2021
A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.
New malaria vaccine proves highly effective – and COVID shows how quickly it could be deployed
General Research
28 April 2021
Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine
Coronavirus COVID-19 General Research
23 April 2021
COVID-19 infections fell significantly – by 65% - after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study.
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Clinical Trials General Research
23 April 2021
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.
National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines
Coronavirus COVID-19 Research
23 April 2021
Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), is the first to show the impact of vaccination on antibody responses and new infections in a large group of adults from the general population aged 16 years and older.